Mutations in CRBN and other cereblon pathway genes are infrequently associated with acquired resistance to immunomodulatory drugs

Files
Jones2021Mutations-CCBY.pdf (960.73 KB)
Date
2021
Authors
Jones, J. R.
Barber, A.
Le Bihan, Y-V
Weinhold, N.
Ashby, C.
Walker, B. A.
Wardell, C. P.
Wang, H.
Kaiser, M. F.
Jackson, G. H.
Davies, F. E.
Chopra, R.
Morgan, G. J.
Pawlyn, C.
Language
American English
Embargo Lift Date
Department
Graduate Medical Education, School of Medicine
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Springer Nature
Can't use the file because of accessibility barriers? Contact us with the title of the item, permanent link, and specifics of your accommodation need.
Abstract
Description
Keywords
Multiple myeloma, Tumor biomarkers, Neoplasm drug resistance
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Jones JR, Barber A, Le Bihan YV, et al. Mutations in CRBN and other cereblon pathway genes are infrequently associated with acquired resistance to immunomodulatory drugs. Leukemia. 2021;35(10):3017-3020. doi:10.1038/s41375-021-01373-4
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Leukemia
Rights
Attribution 4.0 International Creative Commons licenses
Source
PMC
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Permanent Link
https://hdl.handle.net/1805/42312
DOI
https://doi.org/10.1038/s41375-021-01373-4
Version
Final published version
Full Text Available at
This item is under embargo {{howLong}}
Collections
Open Access Policy Articles
Graduate Medical Education Works